WooGene B&G Co. Ltd (018620) - Total Liabilities

Latest as of September 2025: ₩50.21 Billion KRW ≈ $34.03 Million USD

Based on the latest financial reports, WooGene B&G Co. Ltd (018620) has total liabilities worth ₩50.21 Billion KRW (≈ $34.03 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

WooGene B&G Co. Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how WooGene B&G Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of WooGene B&G Co. Ltd to evaluate short-term liquidity relative to the company's equity base.

WooGene B&G Co. Ltd Competitors by Total Liabilities

The table below lists competitors of WooGene B&G Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Mind Technology Inc NASDAQ:MIND	USA	$7.40 Million
Advance Synergy Bhd KLSE:1481	Malaysia	RM195.86 Million
Rapala VMC Oyj HE:RAP1V	Finland	€136.60 Million
Woongjin Thinkbig Co Ltd KO:095720	Korea	₩469.93 Billion
Sino Tactful Co Ltd TWO:5481	Taiwan	NT$362.13 Million
Spectral AI Inc. NASDAQ:MDAI	USA	$23.50 Million
Innometry Co. Ltd KQ:302430	Korea	₩12.58 Billion
IBKS No2 SPAC KQ:204840	Korea	₩28.80 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down WooGene B&G Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of WooGene B&G Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.80	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how WooGene B&G Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for WooGene B&G Co. Ltd (2011–2024)

The table below shows the annual total liabilities of WooGene B&G Co. Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩85.08 Billion ≈ $57.66 Million	+72.74%
2023-12-31	₩49.25 Billion ≈ $33.38 Million	-12.37%
2022-12-31	₩56.20 Billion ≈ $38.09 Million	+23.90%
2021-12-31	₩45.36 Billion ≈ $30.74 Million	-4.93%
2020-12-31	₩47.72 Billion ≈ $32.34 Million	-17.54%
2019-12-31	₩57.87 Billion ≈ $39.22 Million	+72.55%
2018-12-31	₩33.54 Billion ≈ $22.73 Million	-10.80%
2017-12-31	₩37.60 Billion ≈ $25.48 Million	+4.42%
2016-12-31	₩36.01 Billion ≈ $24.40 Million	+77.05%
2015-12-31	₩20.34 Billion ≈ $13.78 Million	+142.38%
2014-12-31	₩8.39 Billion ≈ $5.69 Million	+10.11%
2012-12-31	₩7.62 Billion ≈ $5.16 Million	-5.51%
2011-12-31	₩8.06 Billion ≈ $5.47 Million	--

About WooGene B&G Co. Ltd

KQ:018620 Korea Pharmaceuticals

Market Cap

$47.60 Million

₩70.24 Billion KRW

Market Cap Rank

#22159 Global

#1365 in Korea

Share Price

₩2705.00

Change (1 day)

+4.44%

52-Week Range

₩670.00 - ₩3400.00

All Time High

₩6913.04